Is a complete FRA/R7E research report available?

No complete published report is available for fra/R7E (FRA/R7E) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

FRA/R7E (FRA/R7E)

Frankfurt Stock Exchange: FRA/R7E · EUR

€7.06

+0.72 (+11.4%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first FRA/R7E analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	430.8M
Net income (ttm)	-128.4M
EPS (ttm)	-€3.69
Volume	0

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -128.4M
EPS (ttm): -€3.69
Market cap: 430.8M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

All FRA/R7E indicators

Market & fundamental data

Available fields

141

Groups with data

Currency

USD

Showing 141 of 141 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	DE
Employees	100
Employees Change	50%
Employees Change Percent	100
Enterprise value	EUR 292.6M
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-07-12
Industry	Pharmaceutical Preparations
Last refreshed	2026-07-31
Market cap	EUR 430.8M
Price	EUR 7.06
Price currency	EUR
Sic	2834
Symbol	fra/R7E
Website	https://www.helus.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-29.79%
FCF yield	-26.87%
P/B ratio	2.14x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	EUR -128.4M
Profit Per Employee	EUR -1.3M
ROA	-41.35
Roa5y	-38.81
ROCE	-61.52
ROE	-74.6
Roe5y	-64.91
ROIC	-44.92

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-3.94%
Cagr3y	-20.96%
Cagr5y	-40.62%

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	EUR 217.8M
Cash	EUR 136.4M
Current Assets	EUR 160.8M
Current Liabilities	EUR 16.9M
Debt	EUR 0
Equity	EUR 201M
Interest Coverage	-48.88
Liabilities	EUR 16.8M
Long Term Assets	EUR 57M
Long Term Liabilities	EUR -83,844
Net Cash	EUR 136.4M
Net Cash By Market Cap	EUR 31.66
Net Cash Growth	67.43%
Net Debt Equity	EUR -0.68
Tangible Book Value	EUR 143.4M
Tangible Book Value Per Share	EUR 2.78

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	9.52
Net Working Capital	EUR 6.8M
Quick ratio	8.38
Working Capital	EUR 143.2M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-72.1%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-3.94%
200-day SMA	5.1
3Y total return	-50.64%
50-day SMA	4.9
50-day SMA vs 200-day SMA	50under200
5Y total return	-92.62%
All Time High	103.4
All Time High Change	-93.87%
All Time High Date	2021-07-27
All Time Low	3.08
All Time Low Change	106.18%
All Time Low Date	2026-06-11
ATR	0.55
Ch YTD	-20.25
High	7.09
High52	7.95
High52 Date	2025-12-30
High52ch	-11.19%
Low	6.5
Low52	3.08
Low52 Date	2026-06-11
Low52ch	129.59%
Ma50ch	29.49%
Price vs 200-day SMA	24.22%
RSI	55.8
RSI Monthly	46.02
RSI Weekly	59.91
Sharpe ratio	0.63x
Sortino ratio	1.03
Total Return	-72.1%
Tr YTD	-20.25
Tr1m	13.01%
Tr1w	-10.7%
Tr3m	42.15%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -123.7M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	46,843,552%
Net Borrowing	21,224,117.5
Shares Insiders	12.03%
Shares Institutions	31.72%
Shares Qo Q	17.6%
Shares Yo Y	72.1%
Short Ratio	2.68

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -125.2M
Adjusted OCF	-125,007,418
Average Volume	564.65x
Bv Per Share	3.89
CAPEX	EUR -163,052
Ch1m	13.01
Ch1w	-10.7
Ch1y	-3.94
Ch3m	42.15
Ch3y	-50.64
Ch5y	-92.62
Ch6m	10.26
Change	11.36%
Change From Open	8.62
Close	6.34
Days Gap	2.52
Depreciation Amortization	101,108.7
Earnings Date	2026-08-11
EBIT	EUR -123.7M
EBITDA	EUR -123.6M
EPS	EUR -3.69
F Score	2
FCF	EUR -115.7M
FCF EV Yield	-39.55x
Financing CF	171,932,685
Fiscal Year End	March
Goodwill	31,574,688.1
Investing CF	-1,182,130
Is Primary Listing	0
Last Report Date	2026-03-31
Last Split Date	2024-09-19
Last Split Type	Reverse
Ma150	5.06
Ma150ch	25.25%
Ma20	6
Ma20ch	5.63%
Net CF	54,931,313
Next Earnings Date	2026-08-11
Open	6.5
Position In Range	94.92
Ppne	169,967.3
Price Date	2026-07-30
Ptbv Ratio	3
Relative Volume	0.14x
Share Based Comp	9,421,480
Tr6m	10.26%
Volume	0

FRA/R7E (FRA/R7E)

Coverage state: Market snapshot only — no published research

Generate the first FRA/R7E analysis

Price

Financial snapshot

Fair-value bridge

Latest news · FRA/R7E

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All FRA/R7E indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on FRA/R7E

Frequently asked questions